CLL (Chronic Lymphocytic Leukemia),DLBCL (Diffuse Large B Cell Lymphoma),Leukemia,Lymphoma Safety and Efficacy of Pirtobrutinib in Richter Transformation Sep 11, 2024
CLL (Chronic Lymphocytic Leukemia),DLBCL (Diffuse Large B Cell Lymphoma),Leukemia,Lymphoma Role of Gut Microbiome in Lymphoma Development Sep 09, 2024
CLL (Chronic Lymphocytic Leukemia),Leukemia,Lymphoma,MCL (Mantle Cell Lymphoma) Identifying Gaps in CLL and MCL Treatment Decision-Making Aug 28, 2024
CLL (Chronic Lymphocytic Leukemia),Leukemia,SCC (Squamous Cell Carcinoma),Skin Cancer Role of AXL in SCC Development Among Patients With CLL Aug 08, 2024
CLL (Chronic Lymphocytic Leukemia),Leukemia Real-World Effectiveness of Ibrutinib for CLL: OSIRIS Study Jul 30, 2024
CLL (Chronic Lymphocytic Leukemia),Leukemia Pharmacodynamic Parameters and Ibrutinib Response in CLL Jul 23, 2024
CLL (Chronic Lymphocytic Leukemia),Leukemia Pirtobrutinib Shows Promise in BTKi Naïve CLL/SLL: BRUIN Study Jun 14, 2024
CLL (Chronic Lymphocytic Leukemia),DLBCL (Diffuse Large B Cell Lymphoma),Leukemia,Lymphoma Epcoritamab Shows Promise in RT: EPCORE CLL-1 Trial Jun 13, 2024